(Q34726905)

4 August 2017

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy (English)

1 reference

4 August 2017

Donald E Kohan

1

1 reference

4 August 2017

Yili Pritchett

2

1 reference

4 August 2017

Mark Molitch

3

1 reference

4 August 2017

Shihua Wen

4

1 reference

4 August 2017

Tushar Garimella

5

1 reference

4 August 2017

Paul Audhya

6

1 reference

4 August 2017

Dennis L Andress

7

1 reference

4 August 2017

3 March 2011

1 reference

Journal of the American Society of Nephrology

4 August 2017

1 reference

4 August 2017

22

1 reference

4 August 2017

4

1 reference

4 August 2017

763-772

1 reference

Avosentan for overt diabetic nephropathy

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Endothelin, hypertension and chronic kidney disease: new insights

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Biology of endothelin receptors in the collecting duct

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Effect of a multifactorial intervention on mortality in type 2 diabetes

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065231

Projecting the number of patients with end-stage renal disease in the United States to the year 2015

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21372210

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21372210

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1681/ASN.2010080869

1 reference

4 August 2017

1 reference

4 August 2017

1 reference